Procaps Group S.A. (NASDAQ: PROC)
$2.57
+0.0200 ( +0.78% ) 0.6K
Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.
Market Data
Open
$2.57
Previous close
$2.55
Volume
0.6K
Market cap
$283.19M
Day range
$2.51 - $2.58
52 week range
$1.95 - $4.95
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Quarterly Reports | 1 | Jul 10, 2024 |
| 6-k | Quarterly Reports | 3 | Jun 28, 2024 |
| 6-k | Quarterly Reports | 3 | May 20, 2024 |
| 6-k | Quarterly Reports | 3 | May 14, 2024 |
| nt | Quarterly Reports | 1 | May 01, 2024 |
| 6-k | Quarterly Reports | 3 | May 01, 2024 |
| 6-k | Quarterly Reports | 4 | Mar 04, 2024 |
| 6-k | Quarterly Reports | 1 | Jan 24, 2024 |
| 6-k | Quarterly Reports | 3 | Jan 16, 2024 |
| 6-k | Quarterly Reports | 6 | Jan 05, 2024 |